Commonwealth Seed Capital
VC Fund
Frankfort, United States
Commonwealth Seed Capital is an independent investment fund that finances early stage Kentucky businesses.
- Total investments:
- 10
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Commonwealth Seed Capital invests in
Stages Commonwealth Seed Capital invests in
Countries Commonwealth Seed Capital invests in
Investment Focus
Industry
- Pharmaceutical 4 (40%)
- Analytics 3 (30%)
- Health Care 3 (30%)
- Biotechnology 3 (30%)
- Medical 2 (20%)
Stage
- Series A 6 (60%)
- Seed 2 (20%)
- Pre-Seed 1 (10%)
- Series B 1 (10%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Nichefire
|
Nichefire is an AI-power marketing analytics company. | $2.6M / Seed / Jan 07, 2025 | |
Resound
|
Developer of an artificial intelligence podcast editing tool to save time for creators, editors, businesses, networks, and more in the podcasting space. The company helps to record or upload audio, process the files, accept or ignore each edit, and export your edited file. | $1.4M / Pre-Seed / Jul 15, 2022 | |
EdjSports
|
EdjSports is a data science and prescriptive analytics sports firm. EdjSports empowers smarter decision-making with proven predictive and prescriptive analytical models and custom software solutions in the sports industry. | $5M / Series A / Aug 18, 2020 | |
FlyWire
|
Flywire is a patented video technology that translates video-enabled fisher data into actionable insights at a fraction of the cost. They work with fishers and seafood suppliers to provide at-sea verification of sustainable fishing efforts, translating video-enabled fisher data into actionable insights at a fraction of the cost. At FlyWire theycreate technology to verify what happens on the water and deliver the data needed for more sustainable seas and a more transparent supply chain. | $500K / Seed / Jul 01, 2017 | |
Sentry Health
|
SentryHealth is leading the charge in employee health and wellbeing. Our integrated health management solution is the perfect combination of technology and personalized support from caring medical professionals. Powered by AI, we analyze data from multiple sources to develop unique Intelligent Profiles complete with personalized recommendations.Pairing these profiles with smart technology and Registered Nurse Advocates, we engage with each employee to ensure they receive the right care at the right time. The result is better participation, higher satisfaction, greater outcomes, and lower costs. | $4.2M / Series A / Dec 09, 2015 | |
TNG Pharmaceuticals
|
TNG Pharmaceuticals, a Louisville, KY based company is focused on the research and development of our patented vaccine, FlyVax. TNG Pharmaceuticals began at the University of Louisville in the Entrepreneurship MBA program. TNG competed on a global business plan competition circuit: winning four of five competitions, including the world'slargest, richest, and most prestigious competitions. | $4.6M / Series A / Feb 06, 2014 | |
Intranasal Therapeutics
|
Ikano Therapeutics Inc., a specialty pharmaceutical company, focuses on developing nasal spray drug products. | $18M / Series B / Mar 30, 2009 | |
AllTranz
|
AllTranz is a specialty pharmaceutical company developing a unique set of dermal delivery products utilizing two proprietary technology platforms consisting of prodrug development and microneedle formulations. AllTranz will be a leader in the development of innovative drug design strategies delivered via unique dermal product solutions to treatneurological and a variety of other disorders. The broad range of offerings includes solutions for pain modulation, appetite stimulation, smoking cessation, substitution treatment for opiate addiction, as well as alcohol abuse, and abuse deterrent formulations for opiates. AllTranz will utilize its unique dermal drug delivery technology to develop its own products for broad market appeal, as well as partner with pharmaceutical companies seeking to leverage the AllTranz technology platform to improve delivery of existing drugs to form new chemical entities thereby extending patent franchises. | $860K / Series A / Jul 16, 2007 | |
|
Intranasal Therapeutics
|
Ikano Therapeutics Inc., a specialty pharmaceutical company, focuses on developing nasal spray drug products. | $39.1M / Series A / Aug 15, 2006 | |
Allylix
|
Allylix, Inc., an early stage biotechnology company, develops terpene products and their derivatives for the flavor and fragrance, food ingredient, pharmaceutical, agricultural, and biofuel markets. Its products comprise nootkatone, which is a grapefruit flavor that is used in fruit juices and citrus flavored sodas. The company also developssesquiterpenes that are part of aroma chemical segment of the flavor and fragrance market; and production platforms for pharmaceutical, nutraceutical, and agricultural markets. Allylix, Inc. was founded in 2002 and is based in San Diego, California with research and development laboratories in Lexington, Kentucky. | $1.5M / Series A / Aug 30, 2005 |
Co-Investors
Bluegrass Angels
6 deals together
Keyhorse Capital
5 deals together
Keyhorse Capital (KSTC)
4 deals together
Apjohn ventures
2 deals together
Burrill & Company
2 deals together
Fort Washington Capital Partners Group
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Commonwealth Seed Capital invest in?
Commonwealth Seed Capital invests primarily in Pharmaceutical, Analytics and Health Care startups, most often at Series A and Seed stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Commonwealth Seed Capital last invest?
The most recent investment recorded for Commonwealth Seed Capital closed in Jan 2025. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
